Related Experiment Video
Updated: Aug 7, 2026
06:27
Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
Published on: May 6, 2013
The accelerator hypothesis: a unifying explanation for type-1 and type-2 diabetes
1Department of Medicine, Postgraduate Medical School, Derriford Hospital, Plymouth, UK.
Summary
The accelerator hypothesis proposes that type-1 and type-2 diabetes are the same insulin resistance disorder. Weight gain drives this, accelerating beta cell loss and distinguishing diabetes types only by progression speed.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Immunology
Background:
- The etiology of type-1 diabetes remains unknown despite decades of research.
- Type-1 diabetes incidence has tripled, with features overlapping type-2 diabetes.
- Genetic contributions to type-1 diabetes pathogenesis have evolved.
Purpose of the Study:
- To present the accelerator hypothesis unifying type-1 and type-2 diabetes.
- To identify key accelerators of beta cell loss in diabetes development.
- To emphasize the central role of weight gain in the rising incidence of all diabetes.
Main Methods:
- Conceptual framework based on existing research and clinical observations.
- Analysis of contributing factors to beta cell loss: constitution, insulin resistance, and immune response.
- Examination of the impact of weight gain on insulin resistance and beta cell function.
Main Results:
- Type-1 and type-2 diabetes are proposed as the same disorder of insulin resistance with varying genetic backgrounds.
- Three accelerators (constitution, insulin resistance, immune response) variably hasten beta cell loss.
- Weight gain is identified as a prerequisite for diabetes development and a driver of rising incidence.
Conclusions:
- Type-1 diabetes is a subset of type-2 diabetes, distinguished only by the tempo of progression.
- Weight gain and subsequent insulin resistance are central to the development and increasing incidence of all diabetes.
- Controlling weight gain and insulin resistance may prevent both diabetes types by slowing disease progression.
Related Concept Videos
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...